177 related articles for article (PubMed ID: 11358428)
1. Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome.
Zhu X; Chung I; O'Gorman MR; Scholl PR
Clin Immunol; 2001 Jun; 99(3):334-9. PubMed ID: 11358428
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of patients with X-linked Hyper-IgM syndrome: description of two novel CD40L mutations.
Rangel-Santos A; Wakim VL; Jacob CM; Pastorino AC; Cunha JM; Collanieri AC; Niemela JE; Grumach AS; Duarte AJ; Moraes-Vasconcelos D; Oliveira JB
Scand J Immunol; 2009 Feb; 69(2):169-73. PubMed ID: 19170966
[TBL] [Abstract][Full Text] [Related]
3. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
DiSanto JP; Bonnefoy JY; Gauchat JF; Fischer A; de Saint Basile G
Nature; 1993 Feb; 361(6412):541-3. PubMed ID: 8094231
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers.
Callard RE; Smith SH; Herbert J; Morgan G; Padayachee M; Lederman S; Chess L; Kroczek RA; Fanslow WC; Armitage RJ
J Immunol; 1994 Oct; 153(7):3295-306. PubMed ID: 7916370
[TBL] [Abstract][Full Text] [Related]
6. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
[TBL] [Abstract][Full Text] [Related]
7. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM.
Ferrari S; Giliani S; Insalaco A; Al-Ghonaium A; Soresina AR; Loubser M; Avanzini MA; Marconi M; Badolato R; Ugazio AG; Levy Y; Catalan N; Durandy A; Tbakhi A; Notarangelo LD; Plebani A
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12614-9. PubMed ID: 11675497
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand.
Seyama K; Osborne WR; Ochs HD
J Biol Chem; 1999 Apr; 274(16):11310-20. PubMed ID: 10196221
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.
Seyama K; Nonoyama S; Gangsaas I; Hollenbaugh D; Pabst HF; Aruffo A; Ochs HD
Blood; 1998 Oct; 92(7):2421-34. PubMed ID: 9746782
[TBL] [Abstract][Full Text] [Related]
10. Mutations of CD40 ligand in two patients with hyper-IgM syndrome.
García-Pérez MA; Paz-Artal E; Corell A; Moreno A; López-Goyanes A; García-Martín F; Vázquez R; Pacho A; Romo E; Allende LM
Immunobiology; 2003; 207(4):285-94. PubMed ID: 12952351
[TBL] [Abstract][Full Text] [Related]
11. Characterization of soluble CD40 ligand released from human activated platelets.
Jin Y; Nonoyama S; Morio T; Imai K; Ochs HD; Mizutani S
J Med Dent Sci; 2001 Mar; 48(1):23-7. PubMed ID: 12160239
[TBL] [Abstract][Full Text] [Related]
12. Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome.
Bajorath J; Seyama K; Nonoyama S; Ochs HD; Aruffo A
Protein Sci; 1996 Mar; 5(3):531-4. PubMed ID: 16509032
[TBL] [Abstract][Full Text] [Related]
13. [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].
Groeneweg M; Lankester AC; Bredius RG
Ned Tijdschr Geneeskd; 2003 May; 147(21):1009-11. PubMed ID: 12811971
[TBL] [Abstract][Full Text] [Related]
14. Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome.
Duplantier JE; Seyama K; Day NK; Hitchcock R; Nelson RP; Ochs HD; Haraguchi S; Klemperer MR; Good RA
Clin Immunol; 2001 Mar; 98(3):313-8. PubMed ID: 11237554
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China.
An Y; Xiao J; Jiang L; Yang X; Yu J; Zhao X
Scand J Immunol; 2010 Jul; 72(1):50-6. PubMed ID: 20591076
[TBL] [Abstract][Full Text] [Related]
16. Correction of neutropenia and hypogammaglobulinemia in X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.
Scholl PR; O'Gorman MR; Pachman LM; Haut P; Kletzel M
Bone Marrow Transplant; 1998 Dec; 22(12):1215-8. PubMed ID: 9894727
[TBL] [Abstract][Full Text] [Related]
17. Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency.
Tahara M; Pergolizzi RG; Kobayashi H; Krause A; Luettich K; Lesser ML; Crystal RG
Nat Med; 2004 Aug; 10(8):835-41. PubMed ID: 15273748
[TBL] [Abstract][Full Text] [Related]
18. A novel splice-site mutation in the CD40L gene in a patient with X-linked hyper-IgM syndrome.
Dezsö D; Orth U; Heilbronner H; Gal A
Hum Mutat; 1996; 7(2):181-2. PubMed ID: 8829642
[No Abstract] [Full Text] [Related]
19. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.
Bhushan A; Covey LR
Immunol Res; 2001; 24(3):311-24. PubMed ID: 11817328
[TBL] [Abstract][Full Text] [Related]
20. Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome.
Kato T; Tsuge I; Inaba J; Kato K; Matsuyama T; Kojima S
Bone Marrow Transplant; 1999 May; 23(10):1081-3. PubMed ID: 10373076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
